Statin therapy improves serum Annexin A1 levels in patients with acute coronary syndrome
Open Access
- 1 January 2021
- journal article
- research article
- Published by Medknow in International Journal of Critical Illness and Injury Science
- Vol. 11 (1) , 4-8
Abstract
Background: The objective of the study is to estimate the protective role of statins in patients with acute coronary syndrome (ACS) through modulation of annexin A1 (AnxA1) serum levels. Methods: A total number of 63 patients with ACS were recruited compared with 25 healthy control subjects. The enrolments were divided into – Group (A): Patients with ACS on atorvastatin (n = 20), Group (B): Patients with ACS on rosuvastatin (n = 20), Group (C): Patients with ACS but not on statin therapy (n = 23), and Group (D): Healthy controls (n = 25). Body mass index and both systolic blood pressure and diastolic blood pressures were measured. Lipid profile, atherogenic index, cardiac risk ratio, cardiovascular risk index, and human AnxA1 level were estimated. Results: AnxA1 serum level was higher in patients with ACS (3.35 ± 0.84) compared with healthy controls (1.71 ± 0.91) and nonstatin using patients (1.47 ± 0.76) (P = 0.005). Conclusion: AnxA1 serum level is reduced in patients with ACS compared with healthy controls. Patients with ACS on statins therapy showed a higher level of AnxA1 compared with patients with ACS but not on statin therapy.Keywords
This publication has 17 references indexed in Scilit:
- Effects of rosuvastatin on metabolic profile: Versatility of dose-dependent effectJournal of Advanced Pharmaceutical Technology & Research, 2019
- Concept and connotation of oxidative stress in preeclampsiaJournal of Laboratory Physicians, 2018
- Acylation-stimulating protein is a surrogate biomarker for acute myocardial infarction: Role of statinsJournal of Laboratory Physicians, 2017
- Effects of Rosuvastatin Alone or in Combination with Omega-3 Fatty Acid on Adiponectin Levels and Cardiometabolic ProfileJournal of Basic and Clinical Pharmacy, 2017
- The advantageous role of annexin A1 in cardiovascular diseaseCell Adhesion & Migration, 2016
- Simvastatin Up-Regulates Annexin A10 That Can Inhibit the Proliferation, Migration, and Invasion in Androgen-Independent Human Prostate Cancer CellsThe Prostate, 2016
- Implications of Total to High-Density Lipoprotein Cholesterol Ratio Discordance With Alternative Lipid Parameters for Coronary Atheroma Progression and Cardiovascular EventsThe American Journal of Cardiology, 2016
- Assessment of serum prolactin levels in acute myocardial infarction: The role of pharmacotherapyIndian Journal of Endocrinology and Metabolism, 2016
- Smooth muscle cells in human atherosclerosis: Proteomic profiling reveals differences in expression of Annexin A1 and mitochondrial proteins in carotid diseaseJournal of Molecular and Cellular Cardiology, 2013
- 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart DiseaseJACC, 2012